← Back
$SNDX All transactions

Syndax Pharmaceuticals Inc

M 10b5-1 Plan

$ Value

$1.7M

Shares

157,307

Price

$11

Filed

Sep 8

Insider

Name

Metzger Michael A

Title

Chief Executive Officer

CIK

0001507220

Roles

Director Officer

Transaction Details

Transaction Date

2025-09-08

Code

M

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

455,968

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person solely covering equity grants with expiration dates prior to September 10, 2025. Following the sales reported in this Form 4, the Reporting Person has a total of 1,319,634 options to purchase shares of common stock that are vested and immediately exercisable and a total of 651,241 options to purchase shares of common stock that have not yet vested. | The sale prices ranged from $16.21 to $17.06. | This option is fully vested.

Filing Info

Accession No.

0000950170-25-113659

Form Type

4

Issuer CIK

0001395937

Metzger Michael A's History

Date Ticker Type Value
2026-03-24 PYXS A $0
2026-02-09 SNDX $361K
2026-02-06 SNDX $153K
2026-02-04 SNDX A $0
2026-02-04 SNDX A $0
2026-02-04 SNDX A $9.0M
2025-09-08 SNDX M $1.7M
2025-09-08 SNDX $2.6M
2025-09-08 SNDX M $0
2025-07-16 SNDX $70K

Other Insiders at SNDX (90d)

Insider Bought Sold Last
Podlesak Dennis 2026-02-04
Katkin Keith 2026-02-04
Legault Pierre 2026-02-04
Goldan Keith A.
Chief Financial Officer
$115K 2026-02-09
Metzger Michael A
Chief Executive Officer
$514K 2026-02-09
Huber Martin H. Jr. 2026-02-04
Jarrett Jennifer 2026-02-04
Rizo Aleksandra 2026-02-04
Botwood Nicholas A.J.
Head of R&D, CMO
2026-02-04